Population Based Pharmacokinetic and Pharmacodynamic Dosage Model for Cytarabine, Daunorubicin and Etoposide for Acute Myeloid Leukemia
Observational
Observational Model: Cohort, Time Perspective: Prospective
significant covariates from the PK study
after complete analysis of data
No
Ove J Nielsen, MD
Principal Investigator
Rigshospitalet, Denmark
Denmark: Danish Dataprotection Agency
AMLPKPD-20081127
NCT00969891
September 2009
August 2011
Name | Location |
---|